Insider Transactions in Q2 2021 at Eyenovia, Inc. (EYEN)
Insider Transaction List (Q2 2021)
Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
---|---|---|---|---|---|
Jun 17
2021
|
Jennifer G Clasby VP, Regulatory and Clinical |
SELL
Payment of exercise price or tax liability
|
Direct |
14,262
-17.78%
|
$71,310
$5.42 P/Share
|
Jun 17
2021
|
Jennifer G Clasby VP, Regulatory and Clinical |
BUY
Exercise of conversion of derivative security
|
Direct |
24,510
+23.4%
|
$24,510
$1.95 P/Share
|
Jun 15
2021
|
Kenneth B Lee Jr |
BUY
Open market or private purchase
|
Direct |
2,000
+7.31%
|
$10,000
$5.41 P/Share
|
Jun 14
2021
|
Kenneth B Lee Jr |
BUY
Open market or private purchase
|
Direct |
2,000
+7.89%
|
$10,000
$5.47 P/Share
|
Jun 11
2021
|
Kenneth B Lee Jr |
BUY
Open market or private purchase
|
Direct |
2,000
+8.56%
|
$10,000
$5.38 P/Share
|
May 28
2021
|
Charles E Iv Mather Director |
BUY
Open market or private purchase
|
Direct |
3,000
+10.22%
|
$12,000
$4.76 P/Share
|
May 27
2021
|
Michael M Rowe Chief Executive Officer |
BUY
Open market or private purchase
|
Direct |
1,400
+33.33%
|
$5,600
$4.71 P/Share
|
Apr 20
2021
|
Stuart M. Grant |
BUY
Open market or private purchase
|
Direct |
30,000
+0.35%
|
$120,000
$4.75 P/Share
|
Apr 19
2021
|
Stuart M. Grant |
BUY
Open market or private purchase
|
Direct |
30,692
+0.36%
|
$122,768
$4.88 P/Share
|